<DOC>
	<DOCNO>NCT01534793</DOCNO>
	<brief_summary>This observational study aim describe learn curve Holmium Enucleation Prostate ( HoLEP ) technique use LUMENIS laser device senior attend urologist .</brief_summary>
	<brief_title>QUAPELLA ( QUAlity Prostate Enucleation LUMENIS - Laser )</brief_title>
	<detailed_description>This prospective , multicentre observational study study learn curve HoLEP procedure , auto-evaluation quality surgery senior attend urologist introduce HoLEP current clinical practice . This single arm , comparative study . The primary outcome ability surgeon perform 4 HoLEP procedure successfully , accord pre-defined surgical performance scale [ vary 0 5 ] . To successful , procedure must score 5/5 . Each procedure evaluate end surgical act surgeon . As secondary outcome , short term efficacy safety parameter HoLEP technique evaluate follow data prospectively collect : - I-PSS symptom score ( 15 day operation , 6 12 month postoperative ) - I-PSS bother score ( 15 day operation , 1 , 6 12 month postoperative ) - DAN-PSSsex score ( 15 day operation , 6 12 month postoperative ) Global sexual satisfaction ( 15 day operation , 6 12 month postoperative ) - Quality life score QoL-Europe ( 15 day operation , 12 month postoperative ) - Urinary flow rate I-PSS symptom score ( 15 day operation , day 0 , 1 , 6 12 month postoperative ) - Postvoid residual volume ( 15 day operation , day 0 , 1 , 6 12 month postoperative ) - Ultrasound examination prostate ( 15 day operation , 6 12 month postoperative ) - PSA blood testing ( 15 day operation , 6 12 month postoperative ) One month post-operative questionnaire one month post-operative - Evaluation adverse event ( day operation , 1 , 6 12 month postoperative ) - Satisfaction intervention ( 1 12 month postoperative ) - Pathologic examination prostate tissue ( 1 month postoperative ) - Blood level sodium , haemoglobin , haematocrit ( 15 day intervention , immediately intervention , ) Time need step procedure : - prostatic capsule contact - enucleation median lobe - enucleation lateral lobe - hemostasis - morcellation Laser data ( duration , Joules number number fiber use , fibre type , morcellator an nephroscope type ) - Tissue weight - Irrigation volume - Need coagulation another device - Adverse event procedure - Type catheter surgery - Duration catheterization - Post-operative irrigation ( duration , volume , type ) - Hospital stay . The indication surgery usual indication bladder outlet obstruction relief ta context low urinary tract symptom due benign prostatic hyperplasia , alternative level 1 - Grade A recommended surgical technique . The profile every surgeon record term surgical experience age , number previous endoscopic prostatic surgical procedure , number laser procedure . The study design schedule follow : - Inclusion visit ( D-25 D-5 surgery ) , inclusion write informed consent assessment baseline data - Surgical intervention ( D0 ) : perform previously describe literature , assessment perioperative data - One month visit : one month data - Six month visit : six month data - One year visit : one year data Statistical analysis conduct SAS9.2 descriptive analysis data , CUSUM technique main outcome criterion ( Altman et al . Stat Med 1988 7 : 629-637 modelisation learn curve .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>1 . Male patient 50 2 . Classification risk accord American Society Anesthesiologists ( ASA ) score : score 1 , 2 3 3 . Protocol accept patient ( sign inform consent ) 4 . Patient present low urinary tract symptom due benign prostatic hyperplasia , since least 3 month , indication surgical relief bladder outlet obstruction , International prostate symptom score ( IPSS ) ≥ 12 bother score ≥ 3 , full bladder retention , drain catheter suprapubic catheter 5 . Patient maximum urinary flow rate ≤ 12mL/s voiding volume ≥ 125mLat uroflowmetry , patient drain 6 . Prostate weight 40 80 gram 7 . Post void residual volume ≤ 300cc , patient drain 8 . Normal renal function 9 . Non suspect digital rectal examination 10 . PSA value et blood test £ 4 ng/ml , negative prostatic biopsy PSA comprise 4 10 ng/ml patient age &lt; 75 life expectancy &gt; 10 year 11 . Patient oral anticoagulation therapy therapeutic switch possible validated anaesthesiologist prescription anticoagulation therapy 12 . Patient antiplatelet agent treatment interrupt without replacement therapy 5 day prior surgery without increase risk patient safety 13 . Patient give inform consent oppose use data collect study research purpose 14 . Patient treat BPH drug duration type know , treatment stop intervention ( one week surgery plant alphablockers , one week 5alpha reductase inhibitor ) 15 . Patients valid health insurance/coverage . 1 . Patients unstable known cardiac pulmonary disease 2 . Patients severe myasthenia , multiple sclerosis , Parkinson disease know bladder urinary sphincter dysfunction . 3 . Patient history severe pelvic injury cause severe external urinary sphincter damage . 4 . Patient active urinary tract infection 5 . Patient urinary catheter suprapubic catheter reason acute urinary retention due benign prostatic hyperplasia experience need urinate event fill 300cc 6 . Patient neurogenic disease urinary tract 7 . Patient know suspect malignant lesion bladder prostate 8 . Patient history previous prostatic surgery 9 . Patient history bladder stone , major hematuria , urethral stricture , bladder neck stenosis , bladder disease diabetes bladder impairment 10 . Patient prosthesis material region potentially affect surgical procedure . 11 . Patient anorectal disease 12 . Cases surgical indication decide emergency context 13 . Patient predictable incomplete followup 14 . Patient coagulation disease abnormality cover drug belong category cite inclusion criterion 11 12 15 . All patient condition investigator considers exclusion criterion</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Quality assessment</keyword>
	<keyword>Benign Prostatic Hyperplasia</keyword>
	<keyword>Enucleation prostate</keyword>
	<keyword>LUMENIS</keyword>
	<keyword>Laser</keyword>
	<keyword>Learning Curve</keyword>
</DOC>